RP1 + Nivolumab Rejection: Advocating for Patients and Trust in Clinical Trials
FDA Rejects Promising Melanoma Treatment On July 22, 2025, the Food and Drug Administration (FDA) rejected the approval of a…
Blog - Melanoma360
08/26/2025
RP1 + Nivolumab Rejection: Advocating for Patients and Trust in Clinical Trials
FDA Rejects Promising Melanoma Treatment On July 22, 2025, the Food and Drug Administration (FDA) rejected the approval of a…
|
08/12/2025
Remembering Brandon Blackstock: A Call to Action on Melanoma Awareness
Difficult News and A Reminder of the Impact of Melanoma Today we would like to acknowledge the recent death of…
|
08/12/2025
AYA Cancer Conversation: Navigating Young Adult Cancer
We’re excited to share the latest episode of the AIM at Melanoma podcast, featuring an inspiring conversation with Abby Singh,…
|
08/11/2025
IO Biotech Announces Phase 3 Results for Cylembio® + KEYTRUDA® in Advanced Melanoma
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT) today announces topline results from the pivotal Phase…
|
|
07/25/2025
The FDA Said No — Now We Need Your Voice
Dear Friends, A recent FDA decision denied approval of a promising new treatment called RP1 for advanced melanoma—one that showed…
|
|
07/18/2025
Understanding Tumor Genetics and Melanoma: A Recap of Our Latest Webinar
In the age of precision medicine, understanding the genetics of a tumor—not just a person’s inherited DNA—is playing a critical…
|
07/01/2025
The Cost of Sunscreen May Be Costing Lives
Does Price Influence Sunscreen Use? A Closer Look at the Data The cost of sunscreen could be undermining proper usage,…
07/01/2025
A Conversation with Dr. Rena Szabo, PsyD on Empowering Patients
If you or a loved one is facing melanoma or any form of cancer, you know it’s not just a…
|
06/18/2025
Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative
In 2016, the late Valerie Guild—founder and then-president of AIM at Melanoma—attended a melanoma conference and noticed something striking: While…
06/18/2025
Melanoma News and Highlights You Don’t Want to Miss
We know staying informed about melanoma research and treatments is important to you. That’s why we’ve put together some of…
|
Recent Posts
Oct. 22, 2025
SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma
Oct. 20, 2025
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
Oct. 14, 2025
The Power of Peer Support in Melanoma Survivorship
Oct. 07, 2025
You’re Not Out of Options—What To Do After First Line Therapy Fails
Sep. 09, 2025